Predicting Potential Drug Targets Using Tensor Factorisation and Knowledge Graph Embeddings

• URL: http://arxiv.org/abs/2105.10578v1
• Date: Thu, 20 May 2021 16:19:00 GMT
• Title: Predicting Potential Drug Targets Using Tensor Factorisation and Knowledge Graph Embeddings
• Authors: Cheng Ye, Rowan Swiers, Stephen Bonner, Ian Barrett
• Abstract summary: We have developed a new tensor factorisation model to predict potential drug targets (i.e.,genes or proteins) for diseases. We enriched the data with gene representations learned from a drug discovery-oriented knowledge graph and applied our proposed method to predict the clinical outcomes for unseen target and dis-ease pairs.
• Score: 4.415977307120617
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: The drug discovery and development process is a long and expensive one, costing over 1 billion USD on average per drug and taking 10-15 years. To reduce the high levels of attrition throughout the process, there has been a growing interest in applying machine learning methodologies to various stages of drug discovery process in the recent decade, including at the earliest stage - identification of druggable disease genes. In this paper, we have developed a new tensor factorisation model to predict potential drug targets (i.e.,genes or proteins) for diseases. We created a three dimensional tensor which consists of 1,048 targets, 860 diseases and 230,011 evidence attributes and clinical outcomes connecting them, using data extracted from the Open Targets and PharmaProjects databases. We enriched the data with gene representations learned from a drug discovery-oriented knowledge graph and applied our proposed method to predict the clinical outcomes for unseen target and dis-ease pairs. We designed three evaluation strategies to measure the prediction performance and benchmarked several commonly used machine learning classifiers together with matrix and tensor factorisation methods. The result shows that incorporating knowledge graph embeddings significantly improves the prediction accuracy and that training tensor factorisation alongside a dense neural network outperforms other methods. In summary, our framework combines two actively studied machine learning approaches to disease target identification, tensor factorisation and knowledge graph representation learning, which could be a promising avenue for further exploration in data-driven drug discovery.

Related papers

• Multiscale Topology in Interactomic Network: From Transcriptome to Antiaddiction Drug Repurposing [0.3683202928838613]
  The escalating drug addiction crisis in the United States underscores the urgent need for innovative therapeutic strategies. This study embarked on an innovative and rigorous strategy to unearth potential drug repurposing candidates for opioid and cocaine addiction treatment.
  arXiv  Detail & Related papers  (2023-12-03T04:01:38Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• A Deep Learning Approach to the Prediction of Drug Side-Effects on Molecular Graphs [2.4087148947930634]
  We develop a methodology to predict drug side-effects using Graph Neural Networks. We build a dataset from freely accessible and well established data sources. The results show that our method has an improved classification capability, under many parameters and metrics.
  arXiv  Detail & Related papers  (2022-11-30T10:12:41Z)
• LifeLonger: A Benchmark for Continual Disease Classification [59.13735398630546]
  We introduce LifeLonger, a benchmark for continual disease classification on the MedMNIST collection. Task and class incremental learning of diseases address the issue of classifying new samples without re-training the models from scratch. Cross-domain incremental learning addresses the issue of dealing with datasets originating from different institutions while retaining the previously obtained knowledge.
  arXiv  Detail & Related papers  (2022-04-12T12:25:05Z)
• Mining On Alzheimer's Diseases Related Knowledge Graph to Identity Potential AD-related Semantic Triples for Drug Repurposing [13.751910502580415]
  We construct a knowledge graph to study relations between Alzheimer's disease (AD) and chemicals, drugs and dietary supplements. This paper shows that our graph mining model can predict reliable new relationships between AD and other entities.
  arXiv  Detail & Related papers  (2022-02-17T15:33:27Z)
• Self-Supervised Graph Representation Learning for Neuronal Morphologies [75.38832711445421]
  We present GraphDINO, a data-driven approach to learn low-dimensional representations of 3D neuronal morphologies from unlabeled datasets. We show, in two different species and across multiple brain areas, that this method yields morphological cell type clusterings on par with manual feature-based classification by experts. Our method could potentially enable data-driven discovery of novel morphological features and cell types in large-scale datasets.
  arXiv  Detail & Related papers  (2021-12-23T12:17:47Z)
• Demystifying Drug Repurposing Domain Comprehension with Knowledge Graph Embedding [0.058720142291102125]
  Drug repurposing is more relevant than ever due to drug development's rising costs and the need to respond to emerging diseases quickly. Knowledge graph embedding enables drug repurposing using heterogeneous data sources combined with state-of-the-art machine learning models. We propose a structured methodology to understand better machine learning models' results for drug repurposing.
  arXiv  Detail & Related papers  (2021-08-30T08:16:02Z)
• Select-ProtoNet: Learning to Select for Few-Shot Disease Subtype Prediction [55.94378672172967]
  We focus on few-shot disease subtype prediction problem, identifying subgroups of similar patients. We introduce meta learning techniques to develop a new model, which can extract the common experience or knowledge from interrelated clinical tasks. Our new model is built upon a carefully designed meta-learner, called Prototypical Network, that is a simple yet effective meta learning machine for few-shot image classification.
  arXiv  Detail & Related papers  (2020-09-02T02:50:30Z)
• Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response [49.86828302591469]
  In this paper, we apply transfer learning to the prediction of anti-cancer drug response. We apply the classic transfer learning framework that trains a prediction model on the source dataset and refines it on the target dataset. The ensemble transfer learning pipeline is implemented using LightGBM and two deep neural network (DNN) models with different architectures.
  arXiv  Detail & Related papers  (2020-05-13T20:29:48Z)
• Opportunities and Challenges of Deep Learning Methods for Electrocardiogram Data: A Systematic Review [62.490310870300746]
  The electrocardiogram (ECG) is one of the most commonly used diagnostic tools in medicine and healthcare. Deep learning methods have achieved promising results on predictive healthcare tasks using ECG signals. This paper presents a systematic review of deep learning methods for ECG data from both modeling and application perspectives.
  arXiv  Detail & Related papers  (2019-12-28T02:44:29Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.